Figures 3A–F illustrates that the high expression phenotype of miR-3614-5p differentially enriches the P53 pathway, P38MAPK pathway, NK T cell activation, negative T cell selection, response to interleukin 2, and response to tumor cells. The gene discussed is IL2; the disease is neoplasm.